動物用ワクチン市場- 世界の産業規模、シェア、動向、機会、予測、製品別、投与経路別、流通チャネル別、地域別、競合別、2019年～2029年

動物用ワクチンの世界市場は、2023年に76億8,000万米ドルと評価され、2029年までのCAGRは8.18%で、予測期間中に目覚ましい成長を遂げると予測されています。

ワクチンは、その安全性と有効性を保証するために、綿密で厳格な試験と分析のプロセスを経る。この包括的な試験には、数年にわたる大規模な試験が含まれ、新たに開発された抗原の有効性や採用率などの要因が評価されます。治験後の段階では、ワクチンは動物の疾病の発生頻度を維持・管理する上で重要な役割を果たします。これは動物の健康を守るだけでなく、ヒトと動物の相互依存関係を考慮すると、ヒトの健康にも大きな影響を与えます。動物用ワクチンの入手可能性と有効性は、一般大衆が様々な目的で動物に依存していることを推し量る上で不可欠です。最も一般的に使用されている動物ワクチンの中には、狂犬病ワクチン、口蹄疫ワクチン、馬インフルエンザウイルスワクチンがあります。これらのワクチンは、自然に獲得される免疫をシミュレートすることで、感染症の蔓延を防ぐという極めて重要な役割を担っており、その結果、動物と人間の両方の集団を潜在的な感染症から守り、全体的な幸福を確保しています。

主な市場促進要因

世界のペット飼育の増加

政府機関、動物協会、大手企業による取り組み

動物疾病の流行増加

主な市場課題

厳しい規制

ワクチンの高い保管コスト

主要市場動向

研究開発活動の増加

家畜生産の増加

セグメント別インサイト

製品別インサイト

動物タイプ別インサイト

地域別インサイト

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 動物用ワクチンの世界市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別（弱毒生ワクチン,不活化ワクチン,サブユニットワクチン, DNAワクチン,遺伝子組換えワクチン）
  • 動物タイプ別（家畜、コンパニオン、その他）
  • 投与経路別（皮下投与,筋肉内投与,経鼻投与）
  • 流通チャネル別（動物病院,動物クリニック,薬局,その他）
  • 地域別
  • 企業別（2023年）
• 市場マップ

第6章 北米の動物用ワクチン市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別
  • 動物タイプ別
  • 投与経路別
  • 流通チャネル別
  • 国別
• 北米国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の動物用ワクチン市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別
  • 動物タイプ別
  • 投与経路別
  • 流通チャネル別
  • 国別
• 欧州国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の動物用ワクチン市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別
  • 動物タイプ別
  • 投与経路別
  • 流通チャネル別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の動物用ワクチン市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別
  • 動物タイプ別
  • 投与経路別
  • 流通チャネル別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの動物用ワクチン市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別
  • 動物タイプ別
  • 投与経路別
  • 流通チャネル別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併買収（もしあれば）
• 製品上市（もしあれば）
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Zoetis Inc.
• Merck Co., Inc.
• Boehringer Ingelheim International GmbH
• Biogenesis Bago SA
• Indian Immunologicals Ltd.
• ElancoAnimal Health Incorporated
• Phibro Animal Health Corporation
• Neogen Corporation
• Intas Pharmaceuticals Ltd.
• Ouro Fino Saude Animal

第15章 戦略的提言

第16章 免責事項

Global Animal Vaccine Market was valued at USD 7.68 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.18% through 2029. Vaccines undergo a meticulous and rigorous process of testing and analysis, ensuring their safety and efficacy. This comprehensive testing includes extensive trials that span over several years, evaluating factors such as effectiveness and adoption rates of the newly developed antigen. In the post-trial stage, vaccines play a crucial role in maintaining and controlling the frequency of diseases in animals. This not only safeguards animal health but also has a significant impact on human health, considering the interdependence between humans and animals. The availability and effectiveness of animal vaccines are essential in estimating the public's reliance on animals for various purposes. Among the most commonly used animal vaccines are rabies vaccines, foot mouth disease vaccines, and equine influenza virus vaccines. These vaccines play a pivotal role in preventing the spread of infectious agents by simulating naturally acquired immunity, thus protecting both animal and human populations from potential outbreaks and ensuring overall well-being.

Key Market Drivers

Increasing Pet Adoption Globally

Increasing pet adoption globally has brought about a surge in the demand for animal vaccines, reflecting a growing awareness of responsible pet ownership and the need to safeguard the health of our furry companions. As more people open their homes to animals in need, the risk of disease transmission among pets and from pets to humans has also risen. This necessitates comprehensive vaccination programs to ensure the well-being of these beloved family members.

One of the key drivers behind the increased demand for animal vaccines is the desire to prevent the spread of contagious diseases in crowded shelters and homes. Animal shelters, in particular, house numerous animals in close proximity, making them vulnerable to outbreaks of diseases like parvovirus and kennel cough. Vaccinations provide a vital layer of protection, not only ensuring the health of the shelter's residents but also promoting their chances of finding permanent homes.

Furthermore, as pets become more integrated into our lives, there is a growing understanding of zoonotic diseases-ailments that can be transmitted between animals and humans. This realization has led pet owners to seek vaccination for their animals to mitigate the risk of diseases such as rabies, which can be transmitted from infected pets to humans. Consequently, veterinarians are witnessing an upswing in requests for vaccines to protect both the animals and their human companions. There has been a remarkable increase in animal health awareness among the general public. People are now more informed about the importance of regular veterinary care and preventive measures to ensure the well-being of their pets. This growing awareness has led to a surge in the demand for veterinary medicines, including vaccines, driving the global expansion of the animal vaccines market. In conclusion, the rise in pet ownership, coupled with the recognition of the positive impact that companion animals have on human health, has fueled the growth of the animal vaccines market worldwide. As more families embrace their pets as valued members, the demand for effective vaccines to safeguard their health continues to grow.

Initiatives by Government Agencies, Animal Associations, and Leading Players

The demand for animal vaccines has been steadily rising due to proactive initiatives by government agencies, dedicated animal associations, and leading players in the veterinary and pharmaceutical industries. These collaborative efforts are geared towards improving animal health, mitigating disease outbreaks, and ensuring the safety of both domestic and wild animals. Government agencies play a pivotal role in driving this demand. They often implement vaccination programs to control and prevent the spread of contagious diseases in livestock and wildlife populations. These programs not only protect animal populations but also support food security and public health. For example, government-backed campaigns targeting diseases like foot-and-mouth disease and avian influenza have led to a surge in the need for vaccines in the agricultural sector.

Animal associations, including animal welfare organizations and breed-specific clubs, are also making significant contributions. They educate pet owners and breeders about the importance of vaccination in preventing common diseases among companion animals. These associations often collaborate with veterinarians to offer affordable vaccination clinics, increasing accessibility for pet owners and promoting responsible pet ownership.

Leading players in the veterinary and pharmaceutical industries are continually investing in research and development to innovate and produce more effective and efficient vaccines. Their efforts not only meet the growing demand for vaccines but also drive advancements in animal healthcare, resulting in safer and more reliable products.

Increased Prevalence of Animal Disease

Some of the most prevalent diseases among livestock and companion animals are infectious and contagious illnesses. These diseases pose a significant threat to the health and well-being of animals worldwide. For instance, highly infectious diseases such as canine distemper can easily spread through the air, putting other companion animals at risk. Similarly, conditions like foot-and-mouth disease and contagious bovine pleuropneumonia can have devastating effects on livestock, causing economic losses and impacting food production. Given the high prevalence of these diseases, there is an urgent need for effective vaccines to combat them. Vaccination not only plays a crucial role in protecting the animals but also contributes to the overall financial and physical well-being of both humans and animals. By reducing the incidence and severity of these diseases, vaccines can help ensure a healthier and more sustainable livestock and companion animal industry.

As the awareness of the importance of animal vaccines continues to grow, the demand for them is projected to rise. This increasing demand reflects the recognition of the critical role vaccines play in safeguarding animal health and welfare. By addressing the rise in disease incidence among livestock and companion animals, vaccines can contribute to a safer and more resilient animal population.

Key Market Challenges

Stringent Regulatory Regulations

A drug regulatory authority (DRA) plays a crucial role in ensuring the quality, safety, and efficacy of medicinal products. They oversee the entire lifecycle of these products, from manufacturing and distribution to consumer use. With a focus on maintaining product quality throughout the supply chain, DRAs diligently monitor and certify valid commercial promotions. Their responsibilities include licensing products, inspecting and licensing manufacturers and distributors, conducting post-marketing surveillance, regulating claims made for product promotion, and authorizing clinical trials. Obtaining marketing approval for new vaccines from regulatory agencies is not only a complex process but also a costly and time-consuming endeavor. The ability of companies involved in vaccine development to obtain or maintain these regulatory approvals significantly impacts their financial standing. Hence, navigating the regulatory landscape becomes a critical factor in the success of vaccine development initiatives.

High Storage Costs for Vaccines

The growth of animal vaccine demand faces a significant hindrance in the form of high storage costs. The requirement for proper storage and handling of vaccines is essential to maintain their efficacy and safety. This includes maintaining specific temperature ranges, often referred to as the cold chain, which can be both technologically and financially challenging.

The need for specialized refrigeration equipment and infrastructure increases the cost of vaccine storage. Maintaining a consistent and controlled temperature environment is vital for preserving the potency of vaccines, especially for more delicate ones. This necessity means that veterinary clinics, animal shelters, and agricultural facilities must invest in costly refrigeration systems and backup generators to prevent temperature fluctuations, particularly in areas with unreliable power supplies. The expenses associated with monitoring and quality control measures are substantial. Continuous temperature monitoring, calibration, and regular maintenance of refrigeration units are essential to ensure vaccines remain effective. These ongoing costs can strain the budgets of animal healthcare providers and organizations, discouraging them from maintaining an adequate stock of vaccines.

Key Market Trends

Increase in The Number Of RD Activities

An increase in research and development activities aimed at designing effective, efficient, and high-quality vaccines for companion animals, such as dogs and cats, as well as farm animals, including horses, cows, and pigs, is expected to create promising opportunities for the veterinary-animal vaccines market. The launch of new products with improved efficacy and safety profiles will further contribute to the growth of this market. Moreover, significant technological advancements in the development of animal health vaccines, such as the use of novel adjuvants and delivery systems, are anticipated to drive the expansion of the veterinary-animal vaccines market during the forecast period. These advancements will enable the development of vaccines that provide superior protection against infectious diseases and promote better overall animal health.

Additionally, the increasing number of emerging markets, particularly in developing countries, presents a favorable environment for the growth of the veterinary-animal vaccines market. The rising awareness about the importance of animal health, coupled with the growing investments in veterinary infrastructure, will contribute to the increased adoption of vaccines for livestock and companion animals. Furthermore, the growing population of cattle and poultry in developing countries, along with the advancements in healthcare technology, including diagnostics and preventive care, will further accelerate the growth rate of the veterinary-animal vaccines market in the future. This is driven by the need to ensure the health and well-being of animals, which in turn has a direct impact on food security and public health. In conclusion, the veterinary-animal vaccines market is poised for significant growth due to the increasing focus on animal health, technological advancements, expanding markets, and the need for sustainable and safe food production.

Increase in Livestock Production

In livestock farming, veterinary vaccinations play a crucial role in enhancing overall productivity and ensuring the well-being of animals. Given the increasing global population, it is imperative to improve livestock production efficiency and enhance access to high-quality protein in order to meet the growing demand for food. According to the FAO High-Level Expert Forum, a projected global population of 9.1 billion people by 2050 necessitates a 70% increase in overall food production from 2005 levels. Vaccinations that safeguard animal health and bolster the supply chain are indispensable in achieving this objective. Moreover, they help reduce the reliance on antimicrobials for treating infections in both food-producing and companion animals. This is particularly important due to mounting concerns about antibiotic resistance in human and veterinary medicine, as well as the capacity of vaccinations to mitigate the proliferation of organisms that cause foodborne illnesses in humans. These factors contribute significantly to the growth potential of the market in the forecast period.

Segmental Insights

Product Insights

Based on the product, the segment of attenuated live vaccines has emerged as the dominant force in the animal vaccine market, accounting for a significant revenue share in 2023. Live attenuation stands as the oldest vaccination method employed in veterinary medicine, with ongoing trials exploring its potential for additional applications. Notably, this method is being evaluated for the development of protein subunit vaccines for swine, administered intramuscularly. These products play a pivotal role in reducing swine mortality rates and enhancing their overall lifespan amidst disease outbreaks. On the other hand, the recombinant vaccine segment exhibits remarkable growth potential throughout the forecast period. These vaccines effectively mitigate the risk of pathogenicity in animals' post-vaccination. Moreover, recombinant vaccines possess the capability to provide immunization against multiple virus strains, as they can accommodate multiple gene inserts. This unique attribute eliminates the need for adjuvants, enhances vaccine viability, and improves overall stability. Within the realm of veterinary medicine, notable recombinant vaccines include those targeting canine distemper, pseudorabies, Newcastle disease, Lyme disease, and avian influenza.

Animal Type Insights

Based on the animal type, the livestock segment emerged as the dominant force in the market, capturing the highest revenue share. This can be attributed to several factors, including the significant increase in the livestock population, the implementation of supportive government initiatives, and the unfortunate outbreak of diseases among cattle and sheep. Looking ahead, the companion segment is poised to exhibit the fastest growth rate during the forecast period. As pet ownership continues to rise and the demand for animal companionship grows, this segment is expected to flourish, presenting lucrative opportunities for market players.

Regional Insights

North America, comprising the United States and Canada, is estimated to hold the largest market share in the canine disorders industry. The increasing incidence of canine disorders, including but not limited to allergies, respiratory issues, and gastrointestinal problems, has led to a higher adoption of vaccination and preventive measures in the region. This, coupled with the rising pet population and the presence of ongoing research projects and initiatives, is expected to further boost the market in North America. The region's commitment to pet healthcare and continuous advancements in research and development contribute to its dominant position in the market. Efforts are being made to understand the root causes of various canine disorders and develop innovative treatments and therapies to improve the overall well-being of our beloved furry companions. The collaborative efforts of veterinarians, scientists, and pet owners in North America pave the way for advancements in the field of veterinary medicine, ensuring the best possible care for our four-legged friends.

Key Market Players

Zoetis Inc.

Merck Co., Inc.

Boehringer Ingelheim International GmbH

Biogenesis Bago SA

Indian Immunologicals Ltd.

Elanco Animal Health Incorporated

Phibro Animal Health Corporation

Neogen Corporation

Intas Pharmaceuticals Ltd.

Ouro Fino Saude Animal

Report Scope:

In this report, the Global Animal Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Vaccine Market,By Product:

• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

Animal Vaccine Market,By Animal Type:

• Livestock
• Companion
• Others

Animal Vaccine Market,By Route of Administration:

• Subcutaneous
• Intramuscular
• Intranasal

Animal Vaccine Market,By Distribution Channel:

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies Drug Stores
• Others

Animal Vaccine Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Animal Vaccine Market.

Available Customizations:

Global Animal Vaccine marketreport with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validations
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.Global Animal Vaccine Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value
• 5.2.Market Share Forecast
  • 5.2.1.By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
  • 5.2.2.By Animal Type (Livestock, Companion, Others)
  • 5.2.3.By Route Of Administration (Subcutaneous, Intramuscular, Intranasal)
  • 5.2.4.By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies Drug Stores, Others)
  • 5.2.5.By Region
  • 5.2.6.By Company (2023)
• 5.3.Market Map

6.North America Animal Vaccine Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value
• 6.2.Market Share Forecast
  • 6.2.1.ByProduct
  • 6.2.2.By Animal Type
  • 6.2.3.By Route Of Administration
  • 6.2.4.By Distribution Channel
  • 6.2.5.By Country
• 6.3.North America: Country Analysis
  • 6.3.1.United States Animal Vaccine Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Product
      • 6.3.1.2.2.By Animal Type
      • 6.3.1.2.3.By Route Of Administration
      • 6.3.1.2.4.By Distribution Channel
  • 6.3.2.Canada Animal Vaccine Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Product
      • 6.3.2.2.2.By Animal Type
      • 6.3.2.2.3.By Route Of Administration
      • 6.3.2.2.4.By Distribution Channel
  • 6.3.3.Mexico Animal Vaccine Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Product
      • 6.3.3.2.2.By Animal Type
      • 6.3.3.2.3.By Route Of Administration
      • 6.3.3.2.4.By Distribution Channel

7.Europe Animal Vaccine Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value
• 7.2.Market Share Forecast
  • 7.2.1.By Product
  • 7.2.2.By Animal Type
  • 7.2.3.By Route Of Administration
  • 7.2.4.By Distribution Channel
  • 7.2.5.By Country
• 7.3.Europe: Country Analysis
  • 7.3.1.Germany Animal Vaccine Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Product
      • 7.3.1.2.2.By Animal Type
      • 7.3.1.2.3.By Route Of Administration
      • 7.3.1.2.4.By Distribution Channel
  • 7.3.2.United Kingdom Animal Vaccine Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Product
      • 7.3.2.2.2.By Animal Type
      • 7.3.2.2.3.By Route Of Administration
      • 7.3.2.2.4.By Distribution Channel
  • 7.3.3.Italy Animal Vaccine Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecasty
      • 7.3.3.2.1.By Product
      • 7.3.3.2.2.By Animal Type
      • 7.3.3.2.3.By Route Of Administration
      • 7.3.3.2.4.By Distribution Channel
  • 7.3.4.France Animal Vaccine Market Outlook
    • 7.3.4.1.Market Size Forecast
      • 7.3.4.1.1.By Value
    • 7.3.4.2.Market Share Forecast
      • 7.3.4.2.1.By Product
      • 7.3.4.2.2.By Animal Type
      • 7.3.4.2.3.By Route Of Administration
      • 7.3.4.2.4.By Distribution Channel
  • 7.3.5.Spain Animal Vaccine Market Outlook
    • 7.3.5.1.Market Size Forecast
      • 7.3.5.1.1.By Value
    • 7.3.5.2.Market Share Forecast
      • 7.3.5.2.1.By Product
      • 7.3.5.2.2.By Animal Type
      • 7.3.5.2.3.By Route Of Administration
      • 7.3.5.2.4.By Distribution Channel

8.Asia-Pacific Animal Vaccine Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value
• 8.2.Market Share Forecast
  • 8.2.1.By Product
  • 8.2.2.By Animal Type
  • 8.2.3.By Route Of Administration
  • 8.2.4.By Distribution Channel
  • 8.2.5.By Country
• 8.3.Asia-Pacific: Country Analysis
  • 8.3.1.China Animal Vaccine Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Product
      • 8.3.1.2.2.By Animal Type
      • 8.3.1.2.3.By Route Of Administration
      • 8.3.1.2.4.By Distribution Channel
  • 8.3.2.India Animal Vaccine Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Product
      • 8.3.2.2.2.By Animal Type
      • 8.3.2.2.3.By Route Of Administration
      • 8.3.2.2.4.By Distribution Channel
  • 8.3.3.Japan Animal Vaccine Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Product
      • 8.3.3.2.2.By Animal Type
      • 8.3.3.2.3.By Route Of Administration
      • 8.3.3.2.4.By Distribution Channel
  • 8.3.4.South Korea Animal Vaccine Market Outlook
    • 8.3.4.1.Market Size Forecast
      • 8.3.4.1.1.By Value
    • 8.3.4.2.Market Share Forecast
      • 8.3.4.2.1.By Product
      • 8.3.4.2.2.By Animal Type
      • 8.3.4.2.3.By Route Of Administration
      • 8.3.4.2.4.By Distribution Channel
  • 8.3.5.Australia Animal Vaccine Market Outlook
    • 8.3.5.1.Market Size Forecast
      • 8.3.5.1.1.By Value
    • 8.3.5.2.Market Share Forecast
      • 8.3.5.2.1.By Product
      • 8.3.5.2.2.By Animal Type
      • 8.3.5.2.3.By Route Of Administration
      • 8.3.5.2.4.By Distribution Channel

9.South America Animal Vaccine Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value
• 9.2.Market Share Forecast
  • 9.2.1.By Product
  • 9.2.2.By Animal Type
  • 9.2.3.By Route Of Administration
  • 9.2.4.By Distribution Channel
  • 9.2.5.By Country
• 9.3.South America: Country Analysis
  • 9.3.1.Brazil Animal Vaccine Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Product
      • 9.3.1.2.2.By Animal Type
      • 9.3.1.2.3.By Route Of Administration
      • 9.3.1.2.4.By Distribution Channel
  • 9.3.2.Argentina Animal Vaccine Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Product
      • 9.3.2.2.2.By Animal Type
      • 9.3.2.2.3.By Route Of Administration
      • 9.3.2.2.4.By Distribution Channel
  • 9.3.3.Colombia Animal Vaccine Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Product
      • 9.3.3.2.2.By Animal Type
      • 9.3.3.2.3.By Route Of Administration
      • 9.3.3.2.4.By Distribution Channel

10.Middle East and Africa Animal Vaccine Market Outlook

• 10.1.Market Size Forecast
  • 10.1.1.By Value
• 10.2.Market Share Forecast
  • 10.2.1.By Product
  • 10.2.2.By Animal Type
  • 10.2.3.By Route Of Administration
  • 10.2.4.By Distribution Channel
  • 10.2.5.By Country
• 10.3.MEA: Country Analysis
  • 10.3.1.South Africa Animal Vaccine Market Outlook
    • 10.3.1.1.Market Size Forecast
      • 10.3.1.1.1.By Value
    • 10.3.1.2.Market Share Forecast
      • 10.3.1.2.1.By Product
      • 10.3.1.2.2.By Animal Type
      • 10.3.1.2.3.By Route Of Administration
      • 10.3.1.2.4.By Distribution Channel
  • 10.3.2.Saudi Arabia Animal Vaccine Market Outlook
    • 10.3.2.1.Market Size Forecast
      • 10.3.2.1.1.By Value
    • 10.3.2.2.Market Share Forecast
      • 10.3.2.2.1.By Product
      • 10.3.2.2.2.By Animal Type
      • 10.3.2.2.3.By Route Of Administration
      • 10.3.2.2.4.By Distribution Channel
  • 10.3.3.UAE Animal Vaccine Market Outlook
    • 10.3.3.1.Market Size Forecast
      • 10.3.3.1.1.By Value
    • 10.3.3.2.Market Share Forecast
      • 10.3.3.2.1.By Product
      • 10.3.3.2.2.By Animal Type
      • 10.3.3.2.3.By Route Of Administration
      • 10.3.3.2.4.By Distribution Channel

11.Market Dynamics

• 11.1.Drivers
• 11.2.Challenges

12.Market Trends Developments

• 12.1.Merger Acquisition (If Any)
• 12.2.Product Launches (If Any)
• 12.3.Recent Developments

13.Porters Five Forces Analysis

• 13.1.Competition in the Industry
• 13.2.Potential of New Entrants
• 13.3.Power of Suppliers
• 13.4.Power of Customers
• 13.5.Threat of Substitute Products

14.Competitive Landscape

• 14.1.Zoetis Inc.
  • 14.1.1.Business Overview
  • 14.1.2.Company Snapshot
  • 14.1.3.Products Services
  • 14.1.4.Financials (As Reported)
  • 14.1.5.Recent Developments
  • 14.1.6.Key Personnel Details
  • 14.1.7.SWOT Analysis
• 14.2.Merck Co., Inc.
• 14.3.Boehringer Ingelheim International GmbH
• 14.4.Biogenesis Bago SA
• 14.5.Indian Immunologicals Ltd.
• 14.6.ElancoAnimal Health Incorporated
• 14.7.Phibro Animal Health Corporation
• 14.8.Neogen Corporation
• 14.9.Intas Pharmaceuticals Ltd.
• 14.10.Ouro Fino Saude Animal

15.Strategic Recommendations

16.About Us Disclaimer